Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04739202
Title Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) (IMMUNOGAST)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hospices Civils de Lyon
Indications

gastric adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Atezolizumab + Bevacizumab

Atezolizumab + Ipatasertib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.